Bryan Ball
Corporate Officer/Principal presso AADI BIOSCIENCE, INC.
Patrimonio netto: 234 000 $ in data 31/03/2024
Posizioni attive di Bryan Ball
Società | Posizione | Inizio | Fine |
---|---|---|---|
AADI BIOSCIENCE, INC. | Corporate Officer/Principal | 01/08/2022 | - |
Storia della carriera di Bryan Ball
Precedenti posizioni note di Bryan Ball
Società | Posizione | Inizio | Fine |
---|---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Chief Operating Officer | - | 01/08/2022 |
Corporate Officer/Principal | 01/01/2021 | - | |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
IKARIA, INC. | Corporate Officer/Principal | 01/01/2012 | 01/01/2015 |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Corporate Officer/Principal | - | - |
IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01/02/2019 | - |
Formazione di Bryan Ball
Central Michigan University | Undergraduate Degree |
Westminster School | Masters Business Admin |
The University of North Carolina at Charlotte | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
2 |
Posizioni
Corporate Officer/Principal | 6 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Ikaria, Inc.
Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Health Technology |
Aadi Bioscience, Inc. | |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Health Technology |
- Borsa valori
- Insiders
- Bryan Ball
- Esperienza